Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Standard Biotools (LAB) Net Margin (2016 - 2025)

Standard Biotools (LAB) has disclosed Net Margin for 16 consecutive years, with 81.04% as the latest value for Q4 2025.

  • Quarterly Net Margin rose 21855.0% to 81.04% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 67.89% through Dec 2025, up 4863.0% year-over-year, with the annual reading at 87.77% for FY2025, 11540.0% up from the prior year.
  • Net Margin for Q4 2025 was 81.04% at Standard Biotools, up from 162.05% in the prior quarter.
  • The five-year high for Net Margin was 81.04% in Q4 2025, with the low at 338.46% in Q2 2022.
  • Average Net Margin over 5 years is 102.72%, with a median of 77.14% recorded in 2022.
  • The sharpest move saw Net Margin skyrocketed 45818bps in 2021, then crashed -28313bps in 2022.
  • Over 5 years, Net Margin stood at 48.64% in 2021, then crashed by -59bps to 77.14% in 2022, then soared by 163bps to 48.68% in 2023, then tumbled by -382bps to 137.51% in 2024, then skyrocketed by 159bps to 81.04% in 2025.
  • According to Business Quant data, Net Margin over the past three periods came in at 81.04%, 162.05%, and 153.75% for Q4 2025, Q3 2025, and Q2 2025 respectively.